|
C11ORF73 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.223350E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.003700E-03 |
| Normal-vs-Stage2 |
5.973500E-04 |
| Normal-vs-Stage3 |
6.606500E-02 |
| Normal-vs-Stage4 |
1.901510E-02 |
| Stage1-vs-Stage2 |
1.867400E-01 |
| Stage1-vs-Stage3 |
8.038800E-01 |
| Stage1-vs-Stage4 |
8.718200E-01 |
| Stage2-vs-Stage3 |
2.720200E-01 |
| Stage2-vs-Stage4 |
4.249200E-01 |
| Stage3-vs-Stage4 |
7.302400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.372100E-04 |
| Normal-vs-AfricanAmerican |
4.976800E-04 |
| Normal-vs-Asian |
4.619000E-01 |
| Caucasian-vs-AfricanAmerican |
5.214600E-01 |
| Caucasian-vs-Asian |
8.869200E-01 |
| AfricanAmerican-vs-Asian |
9.625200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.356700E-03 |
| Normal-vs-Female |
9.98770000038007E-07 |
| Male-vs-Female |
1.382280E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.797110E-04 |
| Normal-vs-Extreme_Weight |
5.515100E-03 |
| Normal-vs-Obese |
2.813300E-04 |
| Normal-vs-Extreme_Obese |
7.648600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.157180E-01 |
| Normal_Weight-vs-Obese |
8.581400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.655200E-03 |
| Extreme_Weight-vs-Obese |
1.923350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.224000E-02 |
| Obese-vs-Extreme_Obese |
2.648300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.757900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.617900E-04 |
| Normal-vs-Age(61-80Yrs) |
9.593400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.323800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.540810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.001650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.853800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.899200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.414820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.268000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.633600E-04 |
| Normal-VS-Type2 PRCC |
2.133400E-01 |
| Normal-VS-KIRP CIMP |
3.377100E-03 |
| Normal-VS-Unclassified PRCC |
3.921100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.163400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.998100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.323000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.436000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.074200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.087800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.582200E-02 |
| Normal-vs-N1 |
8.875800E-03 |
| Normal-vs-N2 |
4.034400E-01 |
| N0-vs-N1 |
1.997750E-01 |
| N0-vs-N2 |
8.493200E-01 |
| N1-vs-N2 |
4.772800E-01 |
|
|
